Chronic Lymphocytic Leukemia | Fall Oncology Nursing Series: Chronic Lymphocytic Leukemia — Session 3

Featuring perspectives from Dr Anthony Mato and Ms Corinne Hoffman, including the following topics: Introduction: Treatment Adherence and CLL (0:00) Case: A woman in her mid-60s with previously untreated CLL who receives acalabrutinib (12:58) Case: A man in his mid-70s with previously untreated CLL who receives venetoclax/obinutuzumab (22:42) Case: A man in his mid-70s with previously untreated CLL who receives ibrutinib (29:58) Case: A man in his late 60s with CLL who receives acalabrutinib as second-line therapy (36:23) Future Directions in CLL (U2 Regimen, Pirtobrutinib, CAR T-Cell Therapy) (55:39) NCPD information and select publications